94 related articles for article (PubMed ID: 20606453)
1. Evaluation of the symptomatic treatment of residual neurological symptoms in Wilson disease.
Hölscher S; Leinweber B; Hefter H; Reuner U; Günther P; Weiss KH; Oertel WH; Möller JC
Eur Neurol; 2010; 64(2):83-7. PubMed ID: 20606453
[TBL] [Abstract][Full Text] [Related]
2. Medical therapy and botulinum toxin in dystonia.
Jankovic J
Adv Neurol; 1998; 78():169-83. PubMed ID: 9750914
[No Abstract] [Full Text] [Related]
3. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up.
Allescher HD; Storr M; Seige M; Gonzales-Donoso R; Ott R; Born P; Frimberger E; Weigert N; Stier A; Kurjak M; Rösch T; Classen M
Endoscopy; 2001 Dec; 33(12):1007-17. PubMed ID: 11740642
[TBL] [Abstract][Full Text] [Related]
4. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
[TBL] [Abstract][Full Text] [Related]
5. Dystonias and botulinum toxin.
Khadilkar SV
J Assoc Physicians India; 2003 May; 51():443-4. PubMed ID: 12974422
[No Abstract] [Full Text] [Related]
6. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
Whitaker J; Butler A; Semlyen JK; Barnes MP
Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
[TBL] [Abstract][Full Text] [Related]
7. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
[TBL] [Abstract][Full Text] [Related]
8. Focal dystonia in musicians: treatment strategies and long-term outcome in 144 patients.
Jabusch HC; Zschucke D; Schmidt A; Schuele S; Altenmüller E
Mov Disord; 2005 Dec; 20(12):1623-6. PubMed ID: 16078237
[TBL] [Abstract][Full Text] [Related]
9. Effect of botulinum toxin injection for achalasia in Thai patients.
Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
[TBL] [Abstract][Full Text] [Related]
10. Previous endoscopic treatment does not affect complication rate and outcome of laparoscopic Heller myotomy and anterior fundoplication for oesophageal achalasia.
Bonavina L; Incarbone R; Antoniazzi L; Reitano M; Peracchia A
Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):827-30. PubMed ID: 10669988
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: a blinded evaluation.
Racette BA; McGee-Minnich L; Perlmutter JS
Clin Neuropharmacol; 1999; 22(6):337-9. PubMed ID: 10626093
[TBL] [Abstract][Full Text] [Related]
12. [A survey about the accessibility to botulinum toxin therapy for dystonia].
Mezaki T; Hayashi A; Nakase H; Hasegawa K
No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin: a deadly substance with great therapeutic effect.
Holmes S
Prof Nurse; 2003 Oct; 19(2):85-7. PubMed ID: 14593781
[TBL] [Abstract][Full Text] [Related]
14. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
Khan A; Pawar G
W V Med J; 2005; 101(6):258-60. PubMed ID: 16625812
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxins in neurological disease.
Comella CL; Pullman SL
Muscle Nerve; 2004 May; 29(5):628-44. PubMed ID: 15116366
[TBL] [Abstract][Full Text] [Related]
16. [Probing into indication of living-related liver transplantation for Wilson's disease].
Cheng F; Wang XH; Zhang F; Li XC; Li GQ; Sun BC; Kong LB
Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):437-40. PubMed ID: 19595231
[TBL] [Abstract][Full Text] [Related]
17. The position of the head in space: a kinematic analysis in patients with cervical dystonia treated with botulinum toxin.
Albani G; Bulgheroni MV; Mancini F; Mauro A; Fundarò C; Pacchetti C; Sandrini G; Nappi G
Funct Neurol; 2001; 16(2):135-41. PubMed ID: 11495419
[TBL] [Abstract][Full Text] [Related]
18. Effect of dystonia and botulinum toxin treatment on health-related quality of life.
Gudex CM; Hawthorne MR; Butler AG; Duffey P
Mov Disord; 1998 Nov; 13(6):941-6. PubMed ID: 9827619
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter.
Fishman VM; Parkman HP; Schiano TD; Hills C; Dabezies MA; Cohen S; Fisher RS; Miller LS
Am J Gastroenterol; 1996 Sep; 91(9):1724-30. PubMed ID: 8792688
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
Panicker JN; Muthane UB
Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
